The Society For Biomaterials hosted a webinar on Tuesday, May 5, 2020. Dr. Chelsea M. Magin discussed how now more than ever before respiratory diseases are impacting the daily lives of millions of people around the world. While tremendous progress has been made using animal models and traditional cell culture techniques to drive the development of therapies for these diseases, many are still considered irreversible and progressive. This disparity between basic research endeavors and clinical outcomes highlights a critical need to better recapitulate native pulmonary tissues for early testing.
This webinar highlights biomaterial engineering strategies for building in vitro models of lung that can be combined with human cells to capture key aspects of disease and regeneration not otherwise achievable in traditional preclinical models.
Please note: Due to a technical difficulty, the speakers shared webcams were not recorded. The slide presentation begins at the 4:35 mark in the recorded version.
|About the Presenter: Dr. Chelsea M. Magin, is currently an Assistant Professor in the Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine and Bioengineering at the University of Colorado, Anschutz Medical Campus. Her scientific interests focus on using innovative biomaterials and bioengineering approaches to build in vitro models of a variety of respiratory diseases, including pulmonary hypertension, pulmonary fibrosis and lung cancer. Her goal is to better recapitulate the process of disease progression in vivo and in turn contribute innovative approaches to disease prevention and intervention. Dr. Magin extensive expertise in the rapid development and translation of biomaterial solutions to healthcare challenges and has been a member of SFB for over 15 years.|